Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism
2 other identifiers
interventional
144
1 country
1
Brief Summary
In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening tools. The investigators want to see if they are good at identifying children with ASD and children without ASD. The investigators hope this research will make it easier for families to get answers when there are concerns for ASD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2019
CompletedFirst Posted
Study publicly available on registry
February 20, 2019
CompletedStudy Start
First participant enrolled
March 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedResults Posted
Study results publicly available
November 29, 2022
CompletedNovember 29, 2022
October 1, 2022
2.6 years
February 18, 2019
October 31, 2022
October 31, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Accurate Diagnosis of Autism Via Telemedicine
Number of children who are accurately diagnosed with autism via diagnostic evaluation
1 day
Accurate Diagnosis of Developmental Delay Via Telemedicine
Number of children who are accurately diagnosed via diagnostic evaluation
1 day
Study Arms (2)
New to diagnosis
EXPERIMENTALWe will test two telemedicine tools with children who have not been previously diagnosed with autism or developmental delay. The two telemedicine tools are the Screening Tool for Autism in Toddlers (TELE-STAT) and the Autism Spectrum Disorder (ASD-PEDS).
Previously diagnosed
EXPERIMENTALWe will test two telemedicine tools with children who have been previously diagnosed with autism or developmental delay. The two telemedicine tools are the Screening Tool for Autism in Toddlers (TELE-STAT) and the Autism Spectrum Disorder (ASD-PEDS).
Interventions
Structured autism screening tool
Semi-structured autism screening tool
Eligibility Criteria
You may qualify if:
- Children who have been diagnosed with autism or developmental delay
You may not qualify if:
- Children with genetic disorders
- Children with medical complexities, such as blindness or deafness
- Children whose families do not speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Zachary Warren
- Organization
- Vanderbilt University Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Zachary E Warren, PhD
Vanderbilt University Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 18, 2019
First Posted
February 20, 2019
Study Start
March 4, 2019
Primary Completion
September 30, 2021
Study Completion
September 30, 2021
Last Updated
November 29, 2022
Results First Posted
November 29, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share